At a glance
ClinicalIndex Comparison RecordN/ACompleted· 6,915 enrolled
Drug / intervention
Phase Iother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Trends in Modern Phase 1 Oncology Trials
In Brief
An observational study evaluating Phase I for Cancer. Completed, enrolled 6,915 participants across 1 site.
Detailed Summary
Overview of response rate published in recent oncology phase I trials
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCancer
CountriesFrance
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartJan 2014
Primary CompletionJun 2015
Study CompletionJun 2018
First PostedSep 2018
TodayJul 2026
First PostedSep 18, 2018
Enrollment StartJan 1, 2014
Primary CompletionJun 1, 2015
Study CompletionJun 1, 2018
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 7.8 years ago
Interventions
Phase Iother
Chemotherapy, ITK, Hormotherapy, Immunotherapy